CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	11 Months Ended	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ (69,142)	$ 64,707	$ 7,872
Less: Income from discontinued operations, net of income taxes	(1,467)	73,047	8,296
Loss from continuing operations, net of income taxes	(67,675)	(8,340)	(424)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	5,379	8,513	6,591
Amortization of intangibles	2,522	3,957	3,376
Amortization of deferred financing costs	1,813	1,261	1,055
Change in deferred income tax	47,333	(4)	1,153
Compensation under stock-based compensation plans	3,320	6,122	4,467
Loss on disposal of fixed assets	285	156	201
Loss on extinguishment of debt	2,954	0	0
Changes in assets and liabilities, net of acquired business:
Receivables, net of bad debt expense	(4,321)	101,230	(31,690)
Inventory	(1,196)	(15,249)	(2,497)
Prepaid expenses and other assets	(19,284)	3,726	11,211
Accounts payable	2,944	(48,200)	(1,659)
Claims payable	(1,030)	(4,354)	8,729
Amounts due to plan sponsors	6,079	(7,046)	5,437
Accrued interest	5,766	(22)	59
Accrued expenses and other liabilities	(15,494)	8,112	(2,945)
Net cash provided by (used in) operating activities from continuing operations	(33,559)	49,862	3,064
Net cash (used in) provided by operating activities from discontinued operations	12,140	(22,978)	23,905
Net cash provided by operating activities	(21,419)	26,884	26,969
Cash flows from investing activities:
Purchases of property and equipment, net	(6,730)	(10,986)	(7,853)
Cash consideration paid to CHS, net of cash acquired	(92,464)	0	0
Cash consideration paid to DS Pharmacy	(4,969)	(2,935)	0
Cash consideration paid for unconsolidated affiliate, net of cash acquired	0	10,652	0
Net cash used in investing activities from continuing operations	(104,163)	(67,619)	(8,316)
Net cash provided by (used in) investing activities from discontinued operations	(4,120)	161,499	(1,591)
Cash consideration paid for asset acquisitions	0	(43,046)	(463)
Net cash used in investing activities	(108,283)	93,880	(9,907)
Cash flows from financing activities:
Cash consideration paid for Option Health earn-out	(1,000)	0	0
Proceeds from new credit facility, net of fees paid to issuers	319,000	0	0
Borrowings on line of credit	407,277	1,244,050	1,773,644
Repayments on line of credit	(356,430)	(1,307,872)	(1,791,058)
Repayments of capital leases	(348)	(3,278)	(2,635)
Principal payments on CHS long-term debt, paid at closing	(128,952)	0	0
Principal payments on long-term debt	(100,000)	0	0
Repayment of note payable	(2,250)	0	0
Deferred and other financing costs	(11,583)	0	(22)
Net proceeds from exercise of employee stock compensation plans	4,116	8,611	3,198
Surrender of stock to satisfy minimum tax withholding	(128)	(174)	(189)
Net cash (used in) provided by financing activities from continuing operations	129,702	(58,663)	(17,062)
Net cash provided by financing activities from discontinued operations	0	0	0
Net cash (used in) provided by financing activities	129,702	(58,663)	(17,062)
Net change in cash and cash equivalents	0	62,101	0
Cash and cash equivalents - end of period		0	0
Cash and cash equivalents - end of period	0	62,101	0
DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	20,116	25,589	27,528
Cash paid during the period for income taxes, net of refunds	2,565	3,137	1,042
Capital lease obligations incurred to acquire property and equipment	$ 671	$ 20	$ 6,631